vCJD Risk Maps of Europe and the United Kingdom

In response to clients' requests we have developed 
two reference maps of the United Kingdom and Europe
for screening donors for vCJD risk factors.

Map version CJD.001 depicts risk areas and factors as described in the following FDA Guidance document published in January 2002:
Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of 
Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease (vCJD) by Blood and Blood Products

Click here to view map version CJD.001

Map version CJD.002 depicts risk areas and factors as described in the FDA Guidance document published in January 2002
 as well as the additional risk of factor described in the following FDA Draft Guidance published in August 2006:
Draft Guidance for Industry: Amendment (Donor Deferral for Transfusion in France Since 1980) to
"Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of
Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease (vCJD) by Blood and Blood Products"

Click here to view map version CJD.002